SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.08-2.7%Nov 14 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (6029)10/14/1998 4:49:00 PM
From: John F. Dowd  Read Replies (1) of 9523
 
Dear Anthony: From PFE 1997 annual report"Building on the strength of our in-line products, Pfizer is forging ahead with an ambitious R&D program, with more than 170 research projects in discovery and development—more than at any time in our history. In1998, we expect to file for approval of two major new drugs: Tikosyn (dofetilide) to treat atrial fibrillation and Eletriptan for the treatment of migraines. We also plan to file for supplemental indications for Norvasc and Zoloft.

John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext